Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

Get up to date on best practices for community care of patients with indolent B-cell lymphomas with an on-demand webcast and downloadable slides from a CCO live workshop on molecular profiling treatment selection and adverse event management.

Share

Program Content

Activities

Indolent Lymphomas Advances
Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 21, 2022

Expires: June 20, 2023

No activities added yet

Activities

Ab-Based Tx in B-cell Lymphomas
Antibody-Based Therapies for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

BTKi for B-Cell Lymphomas
BTK Inhibitors for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

Bispecific Antibodies in Indolent B-Cell Lymphomas
Bispecific Antibodies in Indolent B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

CAR T-cells for B-Cell Lymphomas
CAR T-cell Therapy in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

IMiDs in B-Cell Lymphomas
Immunomodulatory Drugs (IMiDs) in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

PI3Ki in Indolent B-Cell Lymphomas
PI3K Inhibitors in Indolent B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

Epigenetic therapy in Indolent B-Cell Lymphomas
Epigenetic Therapy in Indolent B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Bristol Myers Squibb

Incyte Corporation